Methylnaltrexone for opioid-induced constipation in advanced illness. - Wikidata - wikimedia - TriplyDB

Methylnaltrexone for opioid-induced constipation in advanced illness.

Methylnaltrexone for opioid-induced constipation in advanced illness.

http://www.wikidata.org/entity/Q33439945

about

Laxatives or methylnaltrexone for the management of constipation in palliative care patients Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)Evolving paradigms in the treatment of opioid-induced bowel dysfunction Recent Updates on the Treatment of Constipation Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction Clinical utility of naloxegol in the treatment of opioid-induced constipation Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments Palliative Care in Older Patients With Cancer Considerations on the use of oxymorphone in geriatric patients Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies Symptom management in the older adult: 2015 update Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.Persistent constipation and abdominal adverse events with newer treatments for constipation.Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial.Opioid-induced constipation: pathophysiology, clinical consequences, and management.Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Update in hospice and palliative care.Intensive Care Unit-acquired infection as a side effect of sedation Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity.Review article: palliative care in gynecologic oncology.Novel opioid antagonists for opioid-induced bowel dysfunction.Prophylactic use of laxative for constipation in critically ill patients Differences between opioids: pharmacological, experimental, clinical and economical perspectives Overview and treatment of opioid-induced constipation.Recent advances in the use of opioids for cancer pain Advances in pharmacotherapy for opioid-induced constipation - a systematic review.Current management strategies and therapeutic targets in chronic constipation.Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital.Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers Methylnaltrexone in the treatment of opioid-induced constipation Opioid receptors in the gastrointestinal tract.Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone.

P2860

Q24234823-875F55F1-E5E2-4CB6-9212-158A4D02FC86 Q24633140-A49C68FF-F91E-4A32-9C31-B8CFB8D18AEF Q26777692-04CA6C53-64BF-4EDE-ABBE-1A02EB049EB6 Q26820242-8BFD6BE7-0AE2-4FC5-863B-F737497D192A Q26995944-796BE0BD-9C5E-48AC-B2AE-81FCE208A157 Q27010907-45D57EB4-3C7D-4E99-8432-0498FEDA4581 Q27023613-05876D03-3FB7-4FDF-8AE4-0B3DF9FDBC65 Q28079705-3D410DA8-738F-43EC-9336-313FE8EBA0ED Q28085144-D6E96368-235C-48F1-9182-098D6B34BF57 Q28252394-33627174-A745-4CC4-9926-5F4097E6B0C6 Q28294194-51842694-789A-426A-AEBB-B9AF467864F5 Q30374202-EB3999F0-FD26-4410-AB8D-59284EC9DA92 Q30657653-D4191D2D-064E-43B9-B1AF-EE47986D65CE Q30989361-FFBD0404-BEEC-4CC6-B06C-F07128CFD224 Q31104772-54F38B27-7187-49FC-B561-A86E9CDB5B03 Q33296232-DBC2BA94-49F6-4D0B-A79F-ADA027F694EB Q33461577-09DA40A3-55D2-42FF-BBC5-BF737FF78888 Q33468562-659A7DA0-92C6-4D92-92EA-C9A55D7BF629 Q33520508-B9BF2CB7-BD1B-418E-8391-90EABC9AD8FD Q33564922-0904CE7B-E485-4AC2-B3E0-344D2ED750D3 Q33635040-2147786C-FECD-440A-925C-10D2884BD792 Q33702325-62EB155A-5E1E-4BBF-85D8-95CF97296FFE Q33715430-FEB407EF-B0B5-4132-8B22-305A337BF209 Q33905264-25213452-FC30-4A99-A718-80A9D79876CD Q33919036-51AE3D9C-F337-48A5-BDB3-386DC533A294 Q33973870-0259E86A-862E-4B95-B4C0-FB47251028F0 Q34085287-A787D512-3889-4F87-936C-853592E4F9BC Q34156710-6DD56935-605C-4C69-A141-F8406747FCD4 Q34191604-45766896-9172-4E89-BC45-B843A2CBD840 Q34195940-B84494F4-38FB-4149-A19A-78B20F0C520C Q34272502-F58EF3BA-207B-4C55-BAB1-CCE0668E0401 Q34352001-D7D6EE52-ED45-40F3-A255-ECEFF5A084BE Q34418203-1D1D1483-8546-4CCD-BF15-B40BF0EE0D32 Q34455604-4C645BE8-079D-4059-8DD1-6097D54A9595 Q34565704-9125E90B-F64C-4A1F-9DA0-55E82D3063D8 Q34614438-4F49F8D2-246F-441B-A85C-4569AAE6BE8F Q34966995-00262A83-4DC2-499E-BA87-8B8171D99ADC Q35026245-33815483-ED1F-4DA8-BC8D-33AA8F1498EF Q35185222-5BB6A494-918F-4714-A826-1B317BAC65FF Q35233407-ABCFAAC4-3779-4CF6-9CF5-D670C0CFA3C0

P2860

Methylnaltrexone for opioid-induced constipation in advanced illness.

http://www.wikidata.org/entity/Q33439945

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Methylnaltrexone for opioid-induced constipation in advanced illness.

@ast

Methylnaltrexone for opioid-induced constipation in advanced illness.

@en

type

label

Methylnaltrexone for opioid-induced constipation in advanced illness.

@ast

Methylnaltrexone for opioid-induced constipation in advanced illness.

@en

prefLabel

Methylnaltrexone for opioid-induced constipation in advanced illness.

@ast

Methylnaltrexone for opioid-induced constipation in advanced illness.

@en

P1433

Q33439945-25B43795-7620-47F6-9293-560C9B774A78

P1476

Q33439945-586F9DA1-2AF0-4899-9AD7-B0CFB648A951

P2093

Q33439945-0D153258-16BA-446E-AEE8-27D27FC1A2C5

Q33439945-10A85CDC-E2F2-47A0-B449-15CE8524BF1C

Q33439945-2A61A4A6-80FF-4280-A2FA-0DB6AE991CFA

Q33439945-312C13D9-E9DB-4115-8E1E-502ED82F52F8

Q33439945-4CD3B17C-4A26-4C33-B1A6-6247EB5B1C49

Q33439945-4E8BAB05-C060-4CA4-8BA6-EF8002FA4679

Q33439945-56CBB4D2-06FB-4C1B-8347-8D0854EA6DC6

Q33439945-AF1CCA1D-6CF4-4B60-AE58-A01E783DE63F

Q33439945-E2CB8388-1682-466A-B059-2F92EF711FF8

P304

Q33439945-195A86E3-5B43-45F5-A877-72ED642C7832

P31

Q33439945-5556B2E1-F2F3-4945-B185-6CE2F294EA50

P356

Q33439945-EEE28096-BDD7-4659-B078-155A5D23926D

P407

Q33439945-CD0CE975-98C0-41BD-AD1C-3823198BDFC0

P433

Q33439945-C1539027-7389-4883-B9C6-46D6E5BFBD22

P478

Q33439945-85FC2679-81E5-479C-95F7-2583BE0D3FC5

P577

Q33439945-74E92E26-9371-4628-B411-02791533C6FF

P5875

Q33439945-A1271824-14F9-451A-B65C-474FD1D610C4

P698

Q33439945-CF3A0F8C-D798-4645-BC23-E20E70D9C13C

P921

Q33439945-8a8c89eb-9c16-4bd0-8919-541469a47a36

P356

P1433

The New England Journal of Medicine

P1476

Methylnaltrexone for opioid-induced constipation in advanced illness.

@en

P2093

Alton B Kremer

http://www.w3.org/2001/XMLSchema#string

Bruce H Chamberlain

http://www.w3.org/2001/XMLSchema#string

Charles Kevin Watt

http://www.w3.org/2001/XMLSchema#string

Gail Austin Cooney

http://www.w3.org/2001/XMLSchema#string

Jay Thomas

http://www.w3.org/2001/XMLSchema#string

Nancy Stambler

http://www.w3.org/2001/XMLSchema#string

Neal E Slatkin

http://www.w3.org/2001/XMLSchema#string

Robert J Israel

http://www.w3.org/2001/XMLSchema#string

Sloan Karver

http://www.w3.org/2001/XMLSchema#string

P304

2332-2343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0707377

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5342117

http://www.w3.org/2001/XMLSchema#string

P698

18509120

http://www.w3.org/2001/XMLSchema#string

P921